There are 2137 resources available
1385P - Analysis of drug-induced RNA expression changes in NSCLC patient-derived explants as a potential tool for personalized therapy choice
Presenter: Evgeny Imyanitov
Session: E-Poster Display
Resources:
Abstract
1386P - Anlotinib combined with whole brain radiation therapy (WBRT) for advanced non-small cell lung cancer with multiple brain metastases: An open-label, single-arm phase II trial
Presenter: xiangzhi Zhu
Session: E-Poster Display
Resources:
Abstract
1387P - Phase Ib study of LXH254 + LTT462 in patients with KRAS- or BRAF-mutant NSCLC
Presenter: Juergen Wolf
Session: E-Poster Display
Resources:
Abstract
1388P - Poziotinib in advanced NSCLC with EGFR or HER2 exon 20 insertion mutation: Initial results from a single site expanded access program
Presenter: Arsela Prelaj
Session: E-Poster Display
Resources:
Abstract
1389P - IFCT-1602 CHIVA2 phase II trial: Nivolumab in previously treated HIV-patients with advanced non-small cell lung cancer (NSCLC)
Presenter: Armelle Lavole
Session: E-Poster Display
Resources:
Abstract
1390P - Impact of adding viagenpumatucel-L to nivolumab in non-small cell lung cancer (NSCLC) patients with low levels of tumour infiltrating lymphocytes
Presenter: Idris Bahce
Session: E-Poster Display
Resources:
Abstract
1391P - Phase III confirmatory efficacy and safety study of proposed bevacizumab biosimilar (MYL-1402O) compared with avastin, in the first-line treatment of patients with stage IV non-squamous non-small cell lung cancer (nsNSCLC)
Presenter: Mark Socinski
Session: E-Poster Display
Resources:
Abstract
1392P - Brigatinib in patients with ALK-positive advanced non-small cell lung cancer pretreated with sequential ALK inhibitors: A multicentric real-world study (BRIGALK study)
Presenter: Renaud Descourt
Session: E-Poster Display
Resources:
Abstract
1393P - Risk of SARS-CoV2-related mortality in non-small cell lung cancer patients treated with first-line immune-oncology alone or in combination with chemotherapy
Presenter: Giuseppe Luigi Banna
Session: E-Poster Display
Resources:
Abstract
1394P - Deep learning model to predict clinical outcomes in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors
Presenter: Arielle Elkrief
Session: E-Poster Display
Resources:
Abstract